Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Repurposing existing drugs for COVID-19: an endocrinology perspective
Flavio Cadegiani
BMC Endocrine Disorders (2020) Vol. 20, Iss. 1
Open Access | Times Cited: 45

Showing 1-25 of 45 citing articles:

Pharmacovigilance‐based drug repurposing: The search for inverse signals via OpenVigil identifies putative drugs against viral respiratory infections
Ruwen Böhm, Claudia Bulin, Vicki Waetzig, et al.
British Journal of Clinical Pharmacology (2021) Vol. 87, Iss. 11, pp. 4421-4431
Open Access | Times Cited: 67
Early Antiandrogen Therapy With Dutasteride Reduces Viral Shedding, Inflammatory Responses, and Time-to-Remission in Males With COVID-19: A Randomized, Double-Blind, Placebo-Controlled Interventional Trial (EAT-DUTA AndroCoV Trial – Biochemical)
Flavio Cadegiani, John McCoy, Carlos Gustavo Wambier, et al.
Cureus (2021)
Open Access | Times Cited: 66
Lack of Effectiveness of Repurposed Drugs for COVID-19 Treatment
Miguel Ángel Martı́nez
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 59
Statins and clinical outcomes with COVID-19: Meta-analyses of observational studies
André Scheen
Diabetes & Metabolism (2020) Vol. 47, Iss. 6, pp. 101220-101220
Open Access | Times Cited: 50
A multicenter, double-blind, randomized, parallel-group, placebo-controlled study to evaluate the efficacy and safety of camostat mesilate in patients with COVID-19 (CANDLE study)
T. Kinoshita, Masahiro Shinoda, Yasuhiro Nishizaki, et al.
BMC Medicine (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 26
Early COVID-19 therapy with azithromycin plus nitazoxanide, ivermectin or hydroxychloroquine in outpatient settings significantly improved COVID-19 outcomes compared to known outcomes in untreated patients
Flavio Cadegiani, Andy Goren, Carlos Gustavo Wambier, et al.
New Microbes and New Infections (2021) Vol. 43, pp. 100915-100915
Open Access | Times Cited: 27
Final Results of a Randomized, Placebo-Controlled, Two-Arm, Parallel Clinical Trial of Proxalutamide for Hospitalized COVID-19 Patients: A Multiregional, Joint Analysis of the Proxa-Rescue AndroCoV Trial
Flavio Cadegiani, Ricardo Ariel Zimerman, Daniel Fonseca, et al.
Cureus (2021)
Open Access | Times Cited: 25
Machine Learning as a Precision-Medicine Approach to Prescribing COVID-19 Pharmacotherapy with Remdesivir or Corticosteroids
Carson Lam, Anna Siefkas, Nicole S. Zelin, et al.
Clinical Therapeutics (2021) Vol. 43, Iss. 5, pp. 871-885
Open Access | Times Cited: 22
ACE Gene Variants Rise the Risk of Severe COVID-19 in Patients With Hypertension, Dyslipidemia or Diabetes: A Spanish Pilot Study
María Íñiguez, Patricia Pérez‐Matute, Pablo Villoslada-Blanco, et al.
Frontiers in Endocrinology (2021) Vol. 12
Open Access | Times Cited: 21
p‐cymene impairs SARS‐CoV‐2 and Influenza A (H1N1) viral replication: In silico predicted interaction with SARS‐CoV‐2 nucleocapsid protein and H1N1 nucleoprotein
Athanassios Panagiotopoulos, Melpomeni Tseliou, Ioannis Karakasiliοtis, et al.
Pharmacology Research & Perspectives (2021) Vol. 9, Iss. 4
Open Access | Times Cited: 20
Androgenetic alopecia and COVID ‐19: A review of the hypothetical role of androgens
Hamideh Moravvej, Mohammad Reza Pourani, Moein Baghani, et al.
Dermatologic Therapy (2021) Vol. 34, Iss. 4
Open Access | Times Cited: 18
Targeting sterol alpha‐14 demethylase of Leishmania donovani to fight against leishmaniasis
Shams Tabrez, Fazlur Rahman, Rahat Ali, et al.
Journal of Cellular Biochemistry (2021) Vol. 122, Iss. 9, pp. 1037-1047
Closed Access | Times Cited: 16
Valproic acid use is associated with diminished risk of contracting COVID-19, and diminished disease severity: Epidemiologic and in vitro analysis reveal mechanistic insights
Amanda L. Watson, Pankil Shah, Doug Lee, et al.
PLoS ONE (2024) Vol. 19, Iss. 8, pp. e0307154-e0307154
Open Access | Times Cited: 2
Androgens and Parkinson's Disease: A Review of Human Studies and Animal Models
Mélanie Bourque, Denis Soulet, Thérèse Di Paolo
Androgens Clinical Research and Therapeutics (2021) Vol. 2, Iss. 1, pp. 294-303
Open Access | Times Cited: 15
The AndroCoV Clinical Scoring for COVID-19 Diagnosis: A Prompt, Feasible, Costless, and Highly Sensitive Diagnostic Tool for COVID-19 Based on a 1757-Patient Cohort
Flavio Cadegiani, Ricardo Ariel Zimerman, Bruno Campello de Souza, et al.
Cureus (2021)
Open Access | Times Cited: 14
Early COVID-19 Therapy with Azithromycin Plus Nitazoxanide, Ivermectin or Hydroxychloroquine in Outpatient Settings Significantly Reduced Symptoms Compared to Known Outcomes in Untreated Patients.
Flavio Cadegiani, Andy Goren, Carlos Gustavo Wambier, et al.
Research Square (Research Square) (2020)
Open Access | Times Cited: 14
Early COVID-19 Therapy with Azithromycin Plus Nitazoxanide, Ivermectin or Hydroxychloroquine in Outpatient Settings Significantly Reduced Symptoms Compared to Known Outcomes in Untreated Patients
Flavio Cadegiani, Andy Goren, Carlos Gustavo Wambier, et al.
medRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 13
A mixture of essential oils from three Cretan Aromatic Plants (thyme, Greek sage and Cretan dittany, CAPeo) inhibits SASR-CoV-2 proliferation:in vitroevidence and a Proof-of-Concept intervention study in mild ambulatory COVID-19-positive patients
Christos Lionis, Ioannis Karakasiliοtis, Elena Petelos, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Closed Access | Times Cited: 10
White button mushroom interrupts tissue AR-mediated TMPRSS2 expression and attenuates pro-inflammatory cytokines in C57BL/6 mice
Xiaoqiang Wang, Desiree Ha, Ryohei Yoshitake, et al.
npj Science of Food (2021) Vol. 5, Iss. 1
Open Access | Times Cited: 10
Proxalutamide (GT0918) Reduces the Rate of Hospitalization in mild-to-moderate COVID-19 Female Patients: A Randomized Double-Blinded Placebo-Controlled Two-Arm Parallel Trial
Flavio Cadegiani, Ricardo Ariel Zimerman, Daniel do Nascimento Fonseca, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 9
Evaluation of the efficacy and safety of oral N‐acetylcysteine in patients with COVID‐19 receiving the routine antiviral and hydroxychloroquine protocol: A randomized controlled clinical trial
Najmolsadat Atefi, Azadeh Goodarzi, Taghi Riahi, et al.
Immunity Inflammation and Disease (2023) Vol. 11, Iss. 11
Open Access | Times Cited: 3
An open-label prospective observational study of antiandrogen and non-antiandrogen early pharmacological approaches in females with mild-to-moderate COVID-19. The Pre-AndroCoV Female Trial
Flavio Cadegiani, Andy Goren, Carlos Gustavo Wambier, et al.
medRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 8
Covid 19-the 21st Century Pandemic: The Novel Coronavirus Outbreak and the Treatment Strategies
Sherin Joseph, Anila Kutty Narayanan
Advanced Pharmaceutical Bulletin (2021)
Open Access | Times Cited: 7
Proxalutamide Improves Inflammatory, Immunologic, and Thrombogenic Markers in Mild-to-Moderate COVID-19 Males and Females: an Exploratory Analysis of a Randomized, Double-Blinded, Placebo-Controlled Trial Early Antiandrogen Therapy (EAT) with Proxalutamide (The EAT-Proxa Biochemical AndroCoV-Trial)
Flavio Cadegiani, Andy Goren, Carlos Gustavo Wambier, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 6
13 cis retinoic acid improved the outcomes of COVID-19 patients. A randomized clinical trial
Mahmoud Elkazzaz, Yousry Esam-Eldin Abo-Amer, Amr Ahmed, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 4
Page 1 - Next Page

Scroll to top